Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Int J Antimicrob Agents. 2015 May;45(5):556-7. doi: 10.1016/j.ijantimicag.2015.01.005. Epub 2015 Feb 10.

Authors

Benjaporn Kunakonvichaya¹, Krit Thirapanmethee¹, Piyatip Khuntayaporn¹, Preecha Montakantikul², Mullika Traidej Chomnawang³

Affiliations

¹ Department of Microbiology, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthaya Road, Rajathevi, Bangkok 10400, Thailand.
² Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthaya Road, Rajathevi, Bangkok 10400, Thailand.
³ Department of Microbiology, Faculty of Pharmacy, Mahidol University, 447 Sri Ayudthaya Road, Rajathevi, Bangkok 10400, Thailand. Electronic address: mullika.tra@mahidol.ac.th.

PMID: 25724628
DOI: 10.1016/j.ijantimicag.2015.01.005

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Carbapenems / pharmacology*
Drug Synergism*
Fosfomycin / pharmacology*
Humans
Microbial Sensitivity Tests
Pseudomonas Infections / microbiology
Pseudomonas aeruginosa / drug effects*
Pseudomonas aeruginosa / isolation & purification
beta-Lactam Resistance*

Substances

Anti-Bacterial Agents
Carbapenems
Fosfomycin